Mereo BioPharma (AgeTech UK) Biomed
Kinase inhibitors and other in pipeline for various, inclusing COPD. Mission is to provide new therapies to patients with chronically debilitating and life limiting rare diseases that have few, if any, other treatment options.
Funding Status:
N/A
Headquarters:
United Kingdom
Founded Date:
N/A
Employee Number:
N/A
Industry:
UK AgeTech 2020
Technology:
AgeTech Companies
Investor Type:
N/A
Number Of Exists:
N/A
Investment Stage:
N/A